Interlinked at LSX Nordic Congress 2025: Building Sustainable HealthTech Ventures

Interlinked was proud to take part in the LSX Nordic Congress 2025 in Bergen, a key event bringing together innovators, investors, and industry leaders across the Nordic healthtech ecosystem.

Our CEO, Katarina Hedbeck, contributed to the congress in two roles—both as a panelist and as a moderator. The panel discussion focused on building sustainable healthtech ventures in today’s funding landscape, tackling some of the most pressing issues facing startups, including:

• Balancing runway management with momentum

• Leveraging grants, crowdfunding, and corporate capital

• Early revenue strategies for clinical devices

• Applying lessons from past successes

• 
  

Katarina was joined by an exceptional group of experts: Sana Alajmovic (Sigrid Therapeutics), Markus Dietrich, PhD (Hadean Ventures), Tamara Alagirova (MONCYTE Health), Maria Tell (Segulah Medical Acceleration), Thomas Unt, Miia Kaye (Tesi), and Ådne Iden Høiland (Eitri), with Sergio Ferreira (Norway Health Tech) as moderator.

Their combined insights offered valuable perspectives on how to navigate the Nordic innovation landscape and ensure that promising clinical solutions can successfully scale.

We extend our thanks to Nadia Moodie (Konneh) and the LSX team for curating such impactful conversations. For Interlinked, events like LSX Nordic are vital opportunities to connect, learn, and advance our mission of bringing ReLink from clinical prototype to real-world impact.